Evaluation of renal quantitative T2* changes on MRI following administration of ferumoxytol as a T2* contrast agent
Sandeep S Hedgire,1 Shaunagh McDermott,1 Gregory R Wojtkiewicz,1 Seyed Mahdi Abtahi,1 Mukesh Harisinghani,1 Jason L Gaglia21Center for Systems Biology, Massachusetts General Hospital, Richard B Simches Research Center, 2Joslin Diabetes Center, Boston, MA, USAPurpose: To evaluate the time-dependent...
Guardado en:
Autores principales: | Hedgire SS, McDermott S, Wojtkiewicz GR, Abtahi SM, Harisinghani M, Gaglia JL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/998980f0d36c4521a6641d565ca7cc4a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Enhanced primary tumor delineation in pancreatic adenocarcinoma using ultrasmall super paramagnetic iron oxide nanoparticle-ferumoxytol: an initial experience with histopathologic correlation
por: Hedgire SS, et al.
Publicado: (2014) -
Quantitative estimation of renal function with dynamic contrast-enhanced MRI using a modified two-compartment model.
por: Bin Chen, et al.
Publicado: (2014) -
Improved sensitivity of cellular MRI using phase-cycled balanced SSFP of ferumoxytol nanocomplex-labeled macrophages at ultrahigh field
por: Shen Y, et al.
Publicado: (2018) -
Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics
por: Hai-yi Wang, et al.
Publicado: (2017) -
Gd2O3 nanoparticles in hematopoietic cells for MRI contrast enhancement
por: Hedlund A, et al.
Publicado: (2011)